JP2021138710A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021138710A5 JP2021138710A5 JP2021081095A JP2021081095A JP2021138710A5 JP 2021138710 A5 JP2021138710 A5 JP 2021138710A5 JP 2021081095 A JP2021081095 A JP 2021081095A JP 2021081095 A JP2021081095 A JP 2021081095A JP 2021138710 A5 JP2021138710 A5 JP 2021138710A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- eye diseases
- diabetic
- rpe
- pvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- 208000002158 Proliferative Vitreoretinopathy Diseases 0.000 claims 2
- 206010038934 Retinopathy proliferative Diseases 0.000 claims 2
- 206010064930 age-related macular degeneration Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 201000011190 diabetic macular edema Diseases 0.000 claims 2
- 208000030533 eye disease Diseases 0.000 claims 2
- 208000002780 macular degeneration Diseases 0.000 claims 2
- 208000021971 neovascular inflammatory vitreoretinopathy Diseases 0.000 claims 2
- 230000006785 proliferative vitreoretinopathy Effects 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000004386 ocular blood flow Effects 0.000 claims 1
- 239000000790 retinal pigment Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023100597A JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662401725P | 2016-09-29 | 2016-09-29 | |
| US62/401,725 | 2016-09-29 | ||
| JP2019517058A JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517058A Division JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023100597A Division JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021138710A JP2021138710A (ja) | 2021-09-16 |
| JP2021138710A5 true JP2021138710A5 (enExample) | 2021-12-23 |
Family
ID=61688114
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517058A Withdrawn JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
| JP2021081095A Pending JP2021138710A (ja) | 2016-09-29 | 2021-05-12 | 眼疾患の処置方法 |
| JP2023100597A Pending JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517058A Withdrawn JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023100597A Pending JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11045435B2 (enExample) |
| EP (1) | EP3518913B1 (enExample) |
| JP (3) | JP2019531296A (enExample) |
| KR (1) | KR102341446B1 (enExample) |
| CN (1) | CN109789115A (enExample) |
| CA (1) | CA3038845C (enExample) |
| MY (1) | MY198731A (enExample) |
| TW (1) | TWI765917B (enExample) |
| WO (1) | WO2018059543A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585196B (zh) * | 2018-06-13 | 2022-11-04 | 郭涛 | 一种治疗及预防眼科疾病的药物及其应用 |
| AU2022283415B2 (en) * | 2021-05-28 | 2025-08-28 | Novelwise Pharmaceutical Corporation | Composition and method for treating a drug-resistant cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006512318A (ja) * | 2002-11-12 | 2006-04-13 | アルコン，インコーポレイテッド | 眼の血管新生もしくは水腫状の疾患および障害を処置するためのヒストンデアセチラーゼインヒビター |
| US20050074497A1 (en) * | 2003-04-09 | 2005-04-07 | Schultz Clyde L. | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
| JP4873904B2 (ja) * | 2005-08-22 | 2012-02-08 | 国立大学法人弘前大学 | 眼血管血流障害改善剤 |
| WO2008123395A1 (ja) * | 2007-03-28 | 2008-10-16 | Santen Pharmaceutical Co., Ltd. | ヒストン脱アセチル化酵素阻害作用を有する化合物を有効成分として含有する眼圧下降剤 |
| CA2630174A1 (en) * | 2007-05-02 | 2008-11-02 | Mitchell Alan Winnik | Loading quantum dots into thermo-responsive microgels by reversible transfer from organic solvents to water |
| WO2009109900A1 (en) | 2008-03-03 | 2009-09-11 | Pharmalight Inc. | Stimulation of ocular retrobulbar flow using ocular irritants |
| PA8840701A1 (es) * | 2008-08-27 | 2010-04-21 | Leo Pharma As | NUEVO RECEPTOR VEGF-2 e INHIBIDORES DE PROTEÍNAS TIROSINA QUINASA Y SU USO FARMACÉUTICO DE LOS MISMOS |
| EP2236503B1 (en) * | 2009-04-03 | 2014-02-26 | NatureWise Biotech & Medicals Corporation | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| US7994357B2 (en) * | 2009-04-03 | 2011-08-09 | Naturewise Biotech & Medicals Corporation | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| EP2277387B1 (en) * | 2009-07-22 | 2016-10-19 | NatureWise Biotech & Medicals Corporation | New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly |
| US9896480B2 (en) * | 2009-11-10 | 2018-02-20 | Allegro Pharmaceuticals, Inc. | Integrin receptor antagonists and their methods of use |
| MX2016013613A (es) * | 2014-04-17 | 2017-02-28 | Teraclón Idf S L | Anticuerpos monoclonales recombinantes vnar neutralizantes del factor de crecimiento del endotelio vascular vegf. |
| US9956254B2 (en) * | 2015-02-26 | 2018-05-01 | Naturewise Biotech & Medicals Corporation | Extract of taiwanese propolis for treating ocular diseases |
-
2017
- 2017-09-29 EP EP17854993.7A patent/EP3518913B1/en active Active
- 2017-09-29 KR KR1020197009679A patent/KR102341446B1/ko active Active
- 2017-09-29 JP JP2019517058A patent/JP2019531296A/ja not_active Withdrawn
- 2017-09-29 TW TW106133818A patent/TWI765917B/zh active
- 2017-09-29 WO PCT/CN2017/104345 patent/WO2018059543A1/en not_active Ceased
- 2017-09-29 CN CN201780056308.XA patent/CN109789115A/zh active Pending
- 2017-09-29 MY MYPI2019001713A patent/MY198731A/en unknown
- 2017-09-29 CA CA3038845A patent/CA3038845C/en active Active
- 2017-09-29 US US15/720,785 patent/US11045435B2/en active Active
-
2021
- 2021-05-12 JP JP2021081095A patent/JP2021138710A/ja active Pending
-
2023
- 2023-06-20 JP JP2023100597A patent/JP2023116748A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105307498B (zh) | 用于治疗眼病的组合物、制剂和方法 | |
| JP2022116191A (ja) | 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法 | |
| CA2899321C (en) | Fluorinated .alpha..nu.integrin antagonists | |
| JP2022081661A5 (enExample) | ||
| CA3036474A1 (en) | Therapeutic agent for an ophthalmic disease comprising a vegf receptor inhibitor | |
| AU2011334617B2 (en) | Folic acid - Ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions | |
| JP2013500977A5 (enExample) | ||
| JP2021138710A5 (enExample) | ||
| JP2021525710A (ja) | 眼充血を治療するための組成物およびそれを用いて眼充血を治療するための方法 | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| WO2021170811A1 (en) | Method of treating eye disease using trpv4 antagonists | |
| JP2017527600A5 (enExample) | ||
| RU2015145134A (ru) | Местное лечение воспалительных офтальмологических заболеваний | |
| KR20210062586A (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| TW202038934A (zh) | 用於治療癌症之口服投予多西紫杉醇（ｄｏｃｅｔａｘｅｌ）和Ｐ－ｇｐ抑制劑的醫療組合 | |
| JP2018533631A (ja) | 網膜疾患の治療のためのミラベグロン | |
| JP2021091608A5 (enExample) | ||
| TWI845578B (zh) | 用於治療癌症之口服愛萊諾迪肯（ｉｒｉｎｏｔｅｃａｎ）與Ｐ－ｇｐ抑制劑的醫療組合 | |
| JP6427843B2 (ja) | 眼疾患治療剤 | |
| RU2326668C2 (ru) | Способ лечения рецидивирующего птеригиума | |
| JP2019534269A5 (enExample) | ||
| JP2020530459A5 (enExample) | ||
| JPWO2022232597A5 (enExample) | ||
| RU2372087C1 (ru) | Способ лечения прогрессирующей (активной) формы субмакулярной неоваскулярной мембраны (снм) | |
| JPWO2021125800A5 (enExample) |